RESUMEN
We report on measurements of the decays of B¯ mesons into the semileptonic final states B¯âD^(*)π^(+)π^(-)â^(-)ν¯, where D^(*) represents a D or D^(*) meson and â^(-) is an electron or a muon. These measurements are based on 471×10^(6) BB ¯ pairs recorded with the BABAR detector at the SLAC asymmetric B factory PEP-II. We determine the branching fraction ratios R_{π^{+}π^{-}}^{(*)}=B(B[over ¯]âD^{(*)}π^{+}π^{-}â^{-}ν[over ¯])/B(B[over ¯]âD^{(*)}â^{-}ν[over ¯]) using events in which the second B meson is fully reconstructed. We find R_{π^{+}π^{-}}=0.067±0.010±0.008 and R_{π^{+}π^{-}}^{*}=0.019±0.005±0.004, where the first uncertainty is statistical and the second is systematic. Based on these results and assuming isospin invariance, we estimate that B[over ¯]âD^{(*)}ππâ^{-}ν[over ¯] decays, where π denotes either a π^{±} and π^{0} meson, account for up to half the difference between the measured inclusive semileptonic branching fraction to charm hadrons and the corresponding sum of previously measured exclusive branching fractions.
RESUMEN
We present a measurement of the asymmetry A_{CP} between same-sign inclusive dilepton samples â^{+}â^{+} and â^{-}â^{-} (â=e, µ) from semileptonic B decays in Ï(4S)âBB[over ¯] events, using the complete data set recorded by the BABAR experiment near the Ï(4S) resonance, corresponding to 471×10^{6} BB[over ¯] pairs. The asymmetry A_{CP} allows comparison between the mixing probabilities P(B[over ¯]^{0}âB^{0}) and P(B^{0}âB[over ¯]^{0}), and therefore probes CP and T violation. The result, A_{CP}=[-3.9±3.5(stat)±1.9(syst)]×10^{-3}, is consistent with the standard model expectation.
RESUMEN
We present a search for a neutral, long-lived particle L that is produced in e+ e- collisions and decays at a significant distance from the e+ e- interaction point into various flavor combinations of two oppositely charged tracks. The analysis uses an e+ e- data sample with a luminosity of 489.1 fb(-1) collected by the BABAR detector at the Ï(4S), Ï(3S), and Ï(2S) resonances and just below the Ï(4S). Fitting the two-track mass distribution in search of a signal peak, we do not observe a significant signal, and set 90% confidence level upper limits on the product of the L production cross section, branching fraction, and reconstruction efficiency for six possible two-body L decay modes as a function of the L mass. The efficiency is given for each final state as a function of the mass, lifetime, and transverse momentum of the candidate, allowing application of the upper limits to any production model. In addition, upper limits are provided on the branching fraction B(BâXsL), where Xs is a strange hadronic system.
RESUMEN
Dark sectors charged under a new Abelian interaction have recently received much attention in the context of dark matter models. These models introduce a light new mediator, the so-called dark photon (A^{'}), connecting the dark sector to the standard model. We present a search for a dark photon in the reaction e^{+}e^{-}âγA^{'}, A^{'}âe^{+}e^{-}, µ^{+}µ^{-} using 514 fb^{-1} of data collected with the BABAR detector. We observe no statistically significant deviations from the standard model predictions, and we set 90% confidence level upper limits on the mixing strength between the photon and dark photon at the level of 10^{-4}-10^{-3} for dark photon masses in the range 0.02-10.2 GeV. We further constrain the range of the parameter space favored by interpretations of the discrepancy between the calculated and measured anomalous magnetic moment of the muon.
RESUMEN
We present results of a search for CP violation in B0- B0 mixing with the BABAR detector. We select a sample of B0âD*- Xâ+ ν decays with a partial reconstruction method and use kaon tagging to assess the flavor of the other B meson in the event. We determine the CP violating asymmetry ACP≡[N(B0B0)-N(B0B0)]/[N(B0B0)+N(B0B0)]=(0.06±0.17(-0.32)(+0.38))%, corresponding to ΔCP=1-|q/p|=(0.29±0.84(-1.61)(+1.88))×10(-3).
RESUMEN
We measure the mass difference Δm0 between the D*(2010)+ and the D0 and the natural linewidth Γ of the transition D*(2010)+ â D0π+. The data were recorded with the BABAR detector at center-of-mass energies at and near the Υ(4S) resonance, and correspond to an integrated luminosity of approximately 477 fb(-1). The D0 is reconstructed in the decay modes D0 â K- π+ and D0 â K- π+ π- π+. For the decay mode D0 â K- π+ we obtain Γ = (83.4±1.7±1.5) keV and Δm0 = (145425.6±0.6±1.7) keV, [corrected] where the quoted errors are statistical and systematic, respectively. For the D0 â K- π+ π- π+ mode we obtain Γ = (83.2±1.5±2.6) keV and Δm0 = (145426.6±0.5±1.9) keV. [corrected] The combined measurements yield Γ = (83.3±1.2±1.4) keV and Δm0 = (145425.9±0.4±1.7) keV; the width is a factor of approximately 12 times more precise than the previous value, while the mass difference is a factor of approximately 6 times more precise.
RESUMEN
The photon spectrum in the inclusive electromagnetic radiative decays of the B meson, B â X(s)γ plus B â X(d)γ, is studied using a data sample of (382.8 ± 4.2) × 10(6)Υ(4S) â BB decays collected by the BABAR experiment at SLAC. The spectrum is used to extract the branching fraction B(B â X(s)γ) = (3.21 ± 0.33) × 10(-4) for E(γ) >1.8 GeV and the direct CP asymmetry A(CP) (B â X(s+d)γ) = 0.057 ± 0.063. The effects of detector resolution and Doppler smearing are unfolded to measure the photon energy spectrum in the B meson rest frame.
Asunto(s)
Modelos Teóricos , Física Nuclear/métodos , Fotones , Mesones , Energía NuclearRESUMEN
Although CP violation in the B meson system has been well established by the B factories, there has been no direct observation of time-reversal violation. The decays of entangled neutral B mesons into definite flavor states (B(0) or B(0)), and J/ψK(L)(0) or ccK(S)(0) final states (referred to as B(+) or B(-)), allow comparisons between the probabilities of four pairs of T-conjugated transitions, for example, B(0) â B(-) and B(-) â B(0), as a function of the time difference between the two B decays. Using 468 × 10(6) BB pairs produced in Υ(4S) decays collected by the BABAR detector at SLAC, we measure T-violating parameters in the time evolution of neutral B mesons, yielding ΔS(T)(+) = -1.37 ± 0.14(stat) ± 0.06(syst) and ΔS(T)(-) = 1.17 ± 0.18(stat) ± 0.11(syst). These nonzero results represent the first direct observation of T violation through the exchange of initial and final states in transitions that can only be connected by a T-symmetry transformation.
RESUMEN
Recent astrophysical and terrestrial experiments have motivated the proposal of a dark sector with GeV-scale gauge boson force carriers and new Higgs bosons. We present a search for a dark Higgs boson using 516 fb(-1) of data collected with the BABAR detector. We do not observe a significant signal and we set 90% confidence level upper limits on the product of the standard model-dark-sector mixing angle and the dark-sector coupling constant.
RESUMEN
Based on the full BABAR data sample, we report improved measurements of the ratios R(D(*))=B(B[over ¯]âD(*)τ(-)ν[over ¯](τ))/B(B[over ¯]âD(*)â(â)(-)ν[over ¯](â)), where â is either e or µ. These ratios are sensitive to new physics contributions in the form of a charged Higgs boson. We measure R(D)=0.440±0.058±0.042 and R(D(*))=0.332±0.024±0.018, which exceed the standard model expectations by 2.0σ and 2.7σ, respectively. Taken together, our results disagree with these expectations at the 3.4σ level. This excess cannot be explained by a charged Higgs boson in the type II two-Higgs-doublet model.
RESUMEN
We search for hadronic decays of a light Higgs boson (A(0)) produced in radiative decays of an Υ(2S) or Υ(3S) meson, ΥâγA(0). The data have been recorded by the BABAR experiment at the Υ(3S) and Υ(2S) center-of-mass energies and include (121.3±1.2)×10(6) Υ(3S) and (98.3±0.9)×10(6) Υ(2S) mesons. No significant signal is observed. We set 90% confidence level upper limits on the product branching fractions B(Υ(nS)âγA(0))B(A(0)âhadrons) (n=2 or 3) that range from 1×10(-6) for an A(0) mass of 0.3 GeV/c(2) to 8×10(-5) at 7 GeV/c(2).
RESUMEN
The present study was undertaken to examine the possibility that cerebral energy metabolism can be fueled by lactate. As a sole energy substrate, lactate supported normal synaptic function in rat hippocampal slices for hours without any sign of deterioration. Slices that were synaptically silent as a result of glucose depletion could be reactivated with lactate to show normal synaptic function. When slices were exposed to the glycolytic inhibitor iodoacetic acid, lactate-supported synaptic function was unaffected, whereas that supported by glucose was completely abolished. This indicated that lactate was metabolized directly via pyruvate to enter the tricarboxylic acid cycle. Thus, under conditions that lead to lactate accumulation (cerebral ischemia) this "end product" may be a useful alternative as a substrate for energy metabolism.
Asunto(s)
Hipocampo/fisiología , Lactatos/farmacología , Sinapsis/fisiología , Animales , Metabolismo Energético , Potenciales Evocados/efectos de los fármacos , Glucosa/farmacología , Glucólisis/efectos de los fármacos , Yodoacetatos/farmacología , Ácido Yodoacético , Lactatos/metabolismo , Ácido Láctico , RatasRESUMEN
BACKGROUND: Parents of chronically ill children face numerous burdens in daily life, which can impair their quality of life (QoL) significantly. Therefore in family-oriented rehabilitation, not only the children themselves, but also their parents receive interventions. These aim at stabilizing parents both mentally and physically to enable them to support their children in the best possible way. This study investigates the effects of an inpatient family-oriented rehabilitation program on the QoL of parents of chronically ill children. PATIENTS: A consecutive sample of 231 mothers and 155 fathers of children suffering from cancer, cardiac diseases or cystic fibrosis participated in the study. METHOD: In a prospective longitudinal study, parental QoL was repeatedly assessed using the Ulm Quality of Life Inventory for Parents (ULQIE) at three different time points: admission to the rehabilitation clinic, discharge after four weeks of inpatient treatment, and at a six-month follow-up. RESULTS: Parental QoL increased markedly during rehabilitation treatment (mothers eta (2)=.326, fathers eta (2)=.249). Moreover, six months after the intervention, parental quality of life was still markedly improved compared to baseline assessment (mothers eta (2)=.259, fathers eta (2)=.069). The child's diagnosis had no effect on the level and course of parental QoL. CONCLUSIONS: Taking part in family-oriented rehabilitation can improve the QoL of parents of children suffering from cancer, cardiac diseases or cystic fibrosis. Such programs could be expected to affect the way chronically ill children cope with their condition and this should be examined in future studies.
Asunto(s)
Enfermedad Crónica/psicología , Enfermedad Crónica/rehabilitación , Terapia Familiar/métodos , Padres/psicología , Calidad de Vida/psicología , Adulto , Niño , Fibrosis Quística/psicología , Fibrosis Quística/rehabilitación , Educación , Femenino , Estudios de Seguimiento , Alemania , Cardiopatías/psicología , Cardiopatías/rehabilitación , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/psicología , Neoplasias/rehabilitación , Admisión del Paciente , Satisfacción del Paciente , Centros de Rehabilitación , Encuestas y Cuestionarios , Adulto JovenRESUMEN
BACKGROUND: N-Acetylcysteine (NAC) is a safe pharmaceutical agent known to protect cells from oxidative damage. Following peripheral nerve transection, NAC has been found to eliminate sensory neuronal loss. This study examines the dose-response relationship of NAC in preventing neuronal death. METHODS AND FINDINGS: The rat sciatic nerve transection model was used, and stereological quantification of sensory neuron survival carried out at two weeks post-axotomy. NAC was administered systemically as an intraperitoneal injection to five groups of rats at a range of doses (1-300 mg/kg/day). Significant neuronal loss was observed in the 1 mg/kg/day dosage group (18.5% loss, p = 0.067 vs. sham treatment). A degree of neuroprotection occurred with 10 mg/kg/day (9.1% loss, p < 0.005 vs. control), whilst there was no significant loss with either 150 or 300 mg/kg/day. CONCLUSIONS: The prevention of sensory neuronal loss with NAC is dose dependent and effective over a wide therapeutic range. This analysis confirms the efficacy of systemic administration and provides a dose framework with which NAC has clinical potential to improve outcome after peripheral nerve trauma.
Asunto(s)
Acetilcisteína/administración & dosificación , Neuronas Aferentes/efectos de los fármacos , Neuronas Aferentes/patología , Nervio Ciático/lesiones , Nervio Ciático/patología , Acetilcisteína/farmacología , Animales , Recuento de Células , Relación Dosis-Respuesta a Droga , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/patología , Ratas , Nervio Ciático/efectos de los fármacos , Heridas y Lesiones/patologíaRESUMEN
In vitro brain slices are the preparation of choice for the detailed examination of local circuit properties in mammalian brain. However it is the investigator's responsibility to verify that the circuits under investigation are indeed confined within the boundaries of the functional region of the slice used. The medium in which the slice is maintained is under the full control of the investigator. This places the burden on the investigator to ensure that: (1) the properties of the medium are fully under control; (2) the effects of the medium on the slice are known; (3) the conditions under which the slice is being maintained bear some reasonable relation to those it enjoys (or endures) in vivo. Generalizations to in vivo conditions must be made with caution. If at all possible, similar studies (perhaps less extensive, due to the greater technical difficulties) should be done in vivo to provide a basis for comparison. Investigators using drugs should be aware of, and respect, the basic pharmacological principles cited in the text. In particular, the substantial freedom the investigator has in defining the extracellular medium should not be abused.
Asunto(s)
Encéfalo/metabolismo , Electrofisiología/métodos , Histocitoquímica/métodos , Microtomía/métodos , Conservación de Tejido/métodos , Animales , Encéfalo/fisiología , Encéfalo/ultraestructuraRESUMEN
A key step in gibberellin biosynthesis is the conversion of ent-kaurenoic acid to ent-7[alpha]-hydroxykaurenoic acid, mediated by the enzyme kaurenoic acid hydroxylase. A cell-free system obtained from Gibberella fujikuroi (Saw.) Wr. was used to characterize kaurenoic acid hydroxylase activity. Microsomal preparations from disrupted fungal cells, in the presence of O2 and NADPH, converted [17-14C]ent-kaurenoic acid to oxidation products that were separated by high-performance liquid chromatography and identified as ent-7[alpha]-hydroxykaurenoic acid and gibberellin A14 by combined gas chromatography-mass spectrometry. Flavin adenine dinucleotide and the chloride salts of several monovalent cations stimulated the conversion of ent-kaurenoic acid to these products, whereas CO and a number of known inhibitors of cytochrome P-450-dependent reactions, including paclobutrazol, tetcyclacis, BAS 111.W, flurprimidol, triarimol, metyrapone, and 1-phenylimida-zole, significantly reduced kaurenoic acid hydroxylase activity. Kaurenoic acid hydroxylase was solubilized from fungal microsomes by treatment with 1 M KCl. The properties of the enzyme noted above suggest that kaurenoic acid hydroxylase from G. fujikuroi is a cytochrome P-450-dependent monooxygenase.
RESUMEN
The rat insulin-like growth factor I (IGF-I) gene is characterized by the presence of multiple mRNA transcripts, which differ in the 5'- and/or 3'-untranslated regions (UTRs). Transcript initiation occurs in either exon 1 or exon 2, giving rise to mRNA species which differ in the length and sequence of the 5'-UTR, while further variation is due to multiple transcription start sites and differential splicing within exon 1. This heterogeneity is indicative of multifaceted regulation of gene expression, and it is likely that differences in the nature of transcript expression reflect cell-specific regulation. As IGF-I is an important factor in skeletal growth and development, the aim of this study was to determine the pattern of transcript expression in rat whole bone and osteoblast-enriched cultures isolated from long bones. The relative proportions of transcripts differing in the 5'-UTR were determined by RNase protection assays and compared to expression in rat liver. These studies revealed a significantly lower expression of exon 2-derived transcripts in bone cells compared to liver (approximately 10% compared to 40% of total transcripts). There were also important differences in start site usage in exon 1 in bone cells. In osteoblastic cells, transcripts initiated at start site 3 were the predominant species (50% +/- 12% of total exon 1-derived mRNAs; Mean +/- SD) whereas the alternately spliced transcripts represented only 20% +/- 3%. This was in contrast to the profile in liver in which 47% +/- 9% of total exon 1-derived transcripts were the alternately spliced mRNAs, but start site 3-initiated transcripts represented only 11% +/- 3%. In addition, the proportion of transcripts initiated at start site 4 was about twofold greater in liver than in bone cells (32% +/- 7% compared to 16% +/- 8%). However, expression of full-length transcripts was similar in both tissues. The distribution in osteoblastic cells reflected that in whole bone. These results demonstrate that the IGF-I transcript profile in bone cells differs to that in liver cells. Since the mRNA variants exhibit different properties, including half-life and translatability, such cell-specific variation in their relative expression is likely to reflect differential regulation of IGF-I in these tissues.
Asunto(s)
Huesos/metabolismo , Factor I del Crecimiento Similar a la Insulina/biosíntesis , ARN Mensajero/biosíntesis , Transcripción Genética/genética , Animales , Células Cultivadas , Cartilla de ADN/genética , Exones/genética , Factor I del Crecimiento Similar a la Insulina/genética , Hígado/metabolismo , Osteoblastos/citología , Osteoblastos/metabolismo , Empalme del ARN/genética , ARN Mensajero/aislamiento & purificación , Ratas , Ratas Sprague-DawleyRESUMEN
The cytolytic peptides melittin and gramicidin S are naturally occurring agents that provide a comparative model for studies of complement, immunotoxin and cell-mediated membrane permeability. Most attempts to characterize cytolytic peptides have used model membrane systems including phospholipid vesicles or erythrocytes. Membrane vesicles permit the use of self-quenching concentrations of fluorescent permeability markers, while erythrocytes release measurable hemoglobin. Attempts at measuring early membrane permeability changes in nucleated mammalian cells have been limited. To measure the kinetics of mammalian cell membrane permeability changes induced by cytolytic peptides, we developed a 96-well fluorescence cytolysis assay using the cytoplasmic fluorescent dye calcein as the membrane permeability marker. To facilitate rapid assessment of membrane permeability, trypan blue was added to the assay solution to quench (a) released fluorescence and (b) retained intracellular fluorescence. Trypan blue also provided a complementary visual assessment of cell viability. Using this assay, a detailed kinetic analysis demonstrated permeability of the cell membranes within seconds of exposure to the cytolytic peptides. The rapid permeabilization of the cell membranes was confirmed by flow cytometry using the calcium indicator dye fluo-3. The assay also demonstrated a second slower phase of marker release over the next several hours. The fluorescence cytolysis assay was able to reliably detect the biphasic permeability changes associated with the melittin and gramicidin S peptides suggesting the potential utility of this assay in the assessment of other cytolytic agents.
Asunto(s)
Permeabilidad de la Membrana Celular/efectos de los fármacos , Citotoxinas/farmacología , Gramicidina/farmacología , Meliteno/farmacología , Péptidos/farmacología , Animales , Línea Celular , Fluoresceínas , Colorantes Fluorescentes , Humanos , Mamíferos , Ovinos , Factores de Tiempo , Azul de TripanoRESUMEN
BACKGROUND: Initially developed for histocompatibility testing, the normal lymphocyte transfer (NLT) reaction involves the intradermal injection of allogeneic lymphocytes from one individual to another. Because of the unique kinetics of the immunological response to allogeneic lymphocytes, the NLT reaction has been considered an informative system for the analysis of transplant immunity. METHODS: In this study, we used bilateral efferent lymph duct cannulations in sheep to examine the regional lymphatic response to the NLT reaction. Our studies used monoclonal antibodies to define lymphocyte population dynamics and DNA flow cytometry to reflect lymphocyte proliferative responses. RESULTS: The results confirmed a biphasic NLT reaction. An unexpected finding was the marked differences between the early and late NLT responses. The early response was characterized by T-lymphocyte proliferation, as reflected by S-phase DNA, which was comparable in both the NLT-stimulated and contralateral control efferent lymphocytes. This bilateral proliferative response was observed in both CD4+ and CD8+ lymphocytes. In contrast, the late response was restricted to the efferent lymph from the NLT-stimulated lymph node. Dual-parameter flow cytometry demonstrated that the dominant component of this unilateral NLT response was CD8+ lymphocytes. CONCLUSIONS: These results suggest important functional distinctions between systemic and regional lymphatic responses to intradermal alloantigens.
Asunto(s)
Prueba de Histocompatibilidad/métodos , Sistema Linfático/fisiología , Transfusión de Linfocitos , Animales , Linfocitos B/fisiología , Linfocitos T CD4-Positivos/citología , Linfocitos T CD8-positivos/citología , Ciclo Celular , División Celular/fisiología , Eritema/inmunología , Inyecciones Intradérmicas , Linfa/citología , Linfa/fisiología , Ganglios Linfáticos/citología , Fenotipo , Ovinos , Linfocitos T/fisiología , Inmunología del TrasplanteRESUMEN
Adenosine deaminase complexing proteins have been localized in four exocrine glands of the rabbit by immunoperoxidase staining employing affinity-purified goat anti-rabbit complexing protein immunoglobulin as the primary antibody. In pancreatic acinar cells and in serous cells of Brunner glands (duodenal glands), staining was concentrated in granular appearing deposits between the nucleus and cell apex. Bile canaliculi, components of the exocrine liver, were also positive for complexing protein. In submaxillary glands, staining was localized in serous demilunes and striated ducts. In each instance staining was blocked by preincubating the primary antibody with complexing protein purified from rabbit kidney.